Asia-Pacific Americas Africa Europe Middle East

HETERO BIOPHARMA LIMITED

Company Profile:

HETERO BIOPHARMA LIMITED Company Introduction

Hetero Biopharma Limited is a leading biopharmaceutical company based in India. It is a subsidiary of Hetero, one of the country's largest pharmaceutical companies. Established with a strong focus on biotechnology and biological products, Hetero Biopharma is dedicated to the research, development, manufacturing, and marketing of high-quality biosimilar drugs. The company aims to make advanced biological therapies accessible and affordable globally, addressing critical unmet medical needs, particularly in areas like oncology, immunology, and nephrology.

Hetero Biopharma's portfolio includes a range of biosimilars for complex diseases, emphasizing innovation and adherence to stringent international quality standards. They operate state-of-the-art manufacturing facilities equipped with advanced technology for cell culture, fermentation, purification, and sterile filling processes. Their operations are compliant with global regulatory requirements, ensuring product safety and efficacy.

Answer: HETERO BIOPHARMA LIMITED is a factory and manufacturer. It is actively involved in the research, development, and large-scale production of biopharmaceutical products.

Enterprise Products

HETERO BIOPHARMA LIMITED manufactures and markets biosimilars and biopharmaceuticals including:

* Adalimumab

* Bevacizumab

* Erythropoietin

* Pegfilgrastim

* Rituximab

* Trastuzumab

Business Registration Information:

Manager:

Dr. B. Partha Saradhi Reddy (Chairman & Managing Director, Hetero Group)

Phone:

+91-40-2370 4923 / 2370 5220 / 2370 5219

E-mail:

info@heterodrugs.com

Official Website:
Address:

Hetero Corporate, 7-2-A2, Industrial Estates, Sanath Nagar, Hyderabad – 500 018, Telangana, India

This content is from AI, the data and information provided is for reference only and is not applicable to investment and purchase decisions. If there is any incorrect information, please contact customer service to correct it.